Interim report
Page 1
mendus Changing the course of cancer treatment Q2 Report on the second quarter 2026
Loading workspace
mendus Changing the course of cancer treatment Q2 Report on the second quarter 2026
Your watchlist and earnings event details are available after you sign in.